Global Sexually Transmitted Disease (STD) Diagnosis Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Sexually Transmitted Disease (STD) Diagnosis Revenue
• 1.4 Market by Type
  • 1.4.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Chlamydia testing
  • 1.4.3 Syphilis testing
  • 1.4.4 Gonorrhoea testing
  • 1.4.5 Herpes simplex virus testing
  • 1.4.6 Human papilloma virus testing
  • 1.4.7 Human immunodeficiency virus testing
• 1.5 Market by Application
  • 1.5.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Application: 2020 VS 2026
  • 1.5.2 Government organizations
  • 1.5.3 Hospitals
  • 1.5.4 Diagnostic clinics
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Perspective (2015-2026)
• 2.2 Global Sexually Transmitted Disease (STD) Diagnosis Growth Trends by Regions
  • 2.2.1 Sexually Transmitted Disease (STD) Diagnosis Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Sexually Transmitted Disease (STD) Diagnosis Historic Market Share by Regions (2015-2020)
  • 2.2.3 Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Sexually Transmitted Disease (STD) Diagnosis Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Sexually Transmitted Disease (STD) Diagnosis Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Market Size
  • 3.1.1 Global Top Sexually Transmitted Disease (STD) Diagnosis Players by Revenue (2015-2020)
  • 3.1.2 Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Concentration Ratio
  • 3.2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Disease (STD) Diagnosis Revenue in 2019
• 3.3 Sexually Transmitted Disease (STD) Diagnosis Key Players Head office and Area Served
• 3.4 Key Players Sexually Transmitted Disease (STD) Diagnosis Product Solution and Service
• 3.5 Date of Enter into Sexually Transmitted Disease (STD) Diagnosis Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Sexually Transmitted Disease (STD) Diagnosis Historic Market Size by Type (2015-2020)
• 4.2 Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020)
• 5.2 Global Sexually Transmitted Disease (STD) Diagnosis Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Sexually Transmitted Disease (STD) Diagnosis Market Size (2015-2020)
• 6.2 Sexually Transmitted Disease (STD) Diagnosis Key Players in North America (2019-2020)
• 6.3 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020)
• 6.4 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size (2015-2020)
• 7.2 Sexually Transmitted Disease (STD) Diagnosis Key Players in Europe (2019-2020)
• 7.3 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020)
• 7.4 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020)

8 China

• 8.1 China Sexually Transmitted Disease (STD) Diagnosis Market Size (2015-2020)
• 8.2 Sexually Transmitted Disease (STD) Diagnosis Key Players in China (2019-2020)
• 8.3 China Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020)
• 8.4 China Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Sexually Transmitted Disease (STD) Diagnosis Market Size (2015-2020)
• 9.2 Sexually Transmitted Disease (STD) Diagnosis Key Players in Japan (2019-2020)
• 9.3 Japan Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020)
• 9.4 Japan Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Size (2015-2020)
• 10.2 Sexually Transmitted Disease (STD) Diagnosis Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020)
• 10.4 Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020)

11 India

• 11.1 India Sexually Transmitted Disease (STD) Diagnosis Market Size (2015-2020)
• 11.2 Sexually Transmitted Disease (STD) Diagnosis Key Players in India (2019-2020)
• 11.3 India Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020)
• 11.4 India Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Sexually Transmitted Disease (STD) Diagnosis Market Size (2015-2020)
• 12.2 Sexually Transmitted Disease (STD) Diagnosis Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020)
• 12.4 Central & South America Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott
  • 13.1.1 Abbott Company Details
  • 13.1.2 Abbott Business Overview
  • 13.1.3 Abbott Sexually Transmitted Disease (STD) Diagnosis Introduction
  • 13.1.4 Abbott Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020))
  • 13.1.5 Abbott Recent Development
• 13.2 Roche
  • 13.2.1 Roche Company Details
  • 13.2.2 Roche Business Overview
  • 13.2.3 Roche Sexually Transmitted Disease (STD) Diagnosis Introduction
  • 13.2.4 Roche Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
  • 13.2.5 Roche Recent Development
• 13.3 Thermo Fisher Scientific
  • 13.3.1 Thermo Fisher Scientific Company Details
  • 13.3.2 Thermo Fisher Scientific Business Overview
  • 13.3.3 Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Introduction
  • 13.3.4 Thermo Fisher Scientific Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
  • 13.3.5 Thermo Fisher Scientific Recent Development
• 13.4 Aposcience
  • 13.4.1 Aposcience Company Details
  • 13.4.2 Aposcience Business Overview
  • 13.4.3 Aposcience Sexually Transmitted Disease (STD) Diagnosis Introduction
  • 13.4.4 Aposcience Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
  • 13.4.5 Aposcience Recent Development
• 13.5 BCR Diagnostics
  • 13.5.1 BCR Diagnostics Company Details
  • 13.5.2 BCR Diagnostics Business Overview
  • 13.5.3 BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Introduction
  • 13.5.4 BCR Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
  • 13.5.5 BCR Diagnostics Recent Development
• 13.6 BD Medical
  • 13.6.1 BD Medical Company Details
  • 13.6.2 BD Medical Business Overview
  • 13.6.3 BD Medical Sexually Transmitted Disease (STD) Diagnosis Introduction
  • 13.6.4 BD Medical Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
  • 13.6.5 BD Medical Recent Development
• 13.7 Biocartis
  • 13.7.1 Biocartis Company Details
  • 13.7.2 Biocartis Business Overview
  • 13.7.3 Biocartis Sexually Transmitted Disease (STD) Diagnosis Introduction
  • 13.7.4 Biocartis Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
  • 13.7.5 Biocartis Recent Development
• 13.8 BioMérieux
  • 13.8.1 BioMérieux Company Details
  • 13.8.2 BioMérieux Business Overview
  • 13.8.3 BioMérieux Sexually Transmitted Disease (STD) Diagnosis Introduction
  • 13.8.4 BioMérieux Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
  • 13.8.5 BioMérieux Recent Development
• 13.9 Bio-Rad
  • 13.9.1 Bio-Rad Company Details
  • 13.9.2 Bio-Rad Business Overview
  • 13.9.3 Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Introduction
  • 13.9.4 Bio-Rad Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
  • 13.9.5 Bio-Rad Recent Development
• 13.10 Cepheid
  • 13.10.1 Cepheid Company Details
  • 13.10.2 Cepheid Business Overview
  • 13.10.3 Cepheid Sexually Transmitted Disease (STD) Diagnosis Introduction
  • 13.10.4 Cepheid Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
  • 13.10.5 Cepheid Recent Development
• 13.11 Danaher
  • 10.11.1 Danaher Company Details
  • 10.11.2 Danaher Business Overview
  • 10.11.3 Danaher Sexually Transmitted Disease (STD) Diagnosis Introduction
  • 10.11.4 Danaher Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
  • 10.11.5 Danaher Recent Development
• 13.12 DiaSorin
  • 10.12.1 DiaSorin Company Details
  • 10.12.2 DiaSorin Business Overview
  • 10.12.3 DiaSorin Sexually Transmitted Disease (STD) Diagnosis Introduction
  • 10.12.4 DiaSorin Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
  • 10.12.5 DiaSorin Recent Development
• 13.13 Quidel
  • 10.13.1 Quidel Company Details
  • 10.13.2 Quidel Business Overview
  • 10.13.3 Quidel Sexually Transmitted Disease (STD) Diagnosis Introduction
  • 10.13.4 Quidel Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
  • 10.13.5 Quidel Recent Development
• 13.14 GenMark Diagnostics
  • 10.14.1 GenMark Diagnostics Company Details
  • 10.14.2 GenMark Diagnostics Business Overview
  • 10.14.3 GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Introduction
  • 10.14.4 GenMark Diagnostics Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
  • 10.14.5 GenMark Diagnostics Recent Development
• 13.15 Hologic
  • 10.15.1 Hologic Company Details
  • 10.15.2 Hologic Business Overview
  • 10.15.3 Hologic Sexually Transmitted Disease (STD) Diagnosis Introduction
  • 10.15.4 Hologic Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
  • 10.15.5 Hologic Recent Development
• 13.16 OraSure Technologies
  • 10.16.1 OraSure Technologies Company Details
  • 10.16.2 OraSure Technologies Business Overview
  • 10.16.3 OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Introduction
  • 10.16.4 OraSure Technologies Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
  • 10.16.5 OraSure Technologies Recent Development
• 13.17 Qualigen
  • 10.17.1 Qualigen Company Details
  • 10.17.2 Qualigen Business Overview
  • 10.17.3 Qualigen Sexually Transmitted Disease (STD) Diagnosis Introduction
  • 10.17.4 Qualigen Revenue in Sexually Transmitted Disease (STD) Diagnosis Business (2015-2020)
  • 10.17.5 Qualigen Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer